Trisomy 18 Syndrome: Clinical Trials

27 trials for Trisomy 18 Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 5 unknown, 2 terminated, 1 active not recruiting. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2

Follow Trisomy 18 Syndrome: new trials by email Literature Review of Trisomy 18 Syndrome trials Research Report on Trisomy 18 Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hematological Profile in Children With Numerical Chromosomal Disorders
Down Syndrome, Turner Syndrome
Not yet recruitingAssiut University1582026-11-022026-10-29
The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment
Pregnant Individuals, Aneuploidy
RecruitingBillionToOne Inc.10002026-01-102026-10-15
Evaluation of Fetal Bladder Emptying During the 11-14 Weeks' Ultrasound Examination as a Negative Predictive Marker for Chromosomal Abnormalities
40-Minute Real-Time First-Trimester Ultrasonography - Chromosomal Aneuploidies (e.g., Trisomy 21, Trisomy 18, Trisomy 13); Prenatal Screening Accuracy
Active not recruitingHaseki Training and Research Hospital2702025-08-282025-09-10
Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies
Vanishing Twin, Trisomy 21
CompletedNatera, Inc.1362021-07-222026-08-17
Feasibility Study of a New Screening Program for Major Aneuploidies (T21, T18, T13) in the Emilia-Romagna Region (SAPERER)
NIPT - Autosomal Aneuploidy
UnknownAzienda Usl di Bologna70002020-01-272020-07-24
Study of Vanadis® NIPT for Non-invasive Prenatal Screening of Trisomies (T21, T18 and T13)
Vanadis NIPT system - Trisomy 21, Trisomy 18
UnknownPerkinElmer, Wallac Oy12002018-06-202018-08-29
VAlidation of a Lower Cost aneUploidy scrEen
SmartNIPT - Down Syndrome, Trisomy 18
CompletedWomen and Infants Hospital of Rhode Island24432017-10-102022-09-22
Clinical Evaluation of the IONA Test for Non-invasive Pre Natal Screening in Twin Pregnancies
Blood sample - Down Syndrome, Patau Syndrome
Not applicableCompletedPremaitha Health10002016-02-012020-06-11
Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Blood sampling for Laboratory Developed Test (LDT) analysis - Down Syndrome, Edwards Syndrome
CompletedProgenity, Inc.7602015-10-012019-08-21
SNP-based Microdeletion and Aneuploidy RegisTry (SMART)
22q11 Deletion Syndrome, DiGeorge Syndrome
CompletedNatera, Inc.209602015-04-012021-01-29
Non-Invasive Screening for Fetal Aneuploidy
Maternal Blood Draw - Down Syndrome, Edwards Syndrome
UnknownProgenity, Inc.3402015-03-012018-08-28
Whole Blood Specimen Collection From Pregnant Subjects
Observational - no intervention - Down Syndrome, Edwards Syndrome
UnknownProgenity, Inc.50002015-03-012020-09-17
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
Down Syndrome, Edwards Syndrome
TerminatedSequenom, Inc.502014-08-012015-09-17
High Risk Multiple Gestation Study
Trisomy 13, Trisomy 18
CompletedNatera, Inc.992014-08-012019-06-13
Prenatal Screening for Down Syndrome With DNAFirst
Trisomy 21, Trisomy 18
CompletedWomen and Infants Hospital of Rhode Island1002014-06-012018-02-22
Non-Invasive Chromosomal Evaluation of Trisomy Study
Aneuploidy, Trisomy 21
CompletedCindy Cisneros20002014-04-012020-04-30
Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood
Integrated prenatal screening for Down's syndrome, Serum QUAD Assay for aneuploidy screening, Semiconductor MPSS NIPT assay using ccfDNA in maternal blood - Trisomy 21, Trisomy 18
Not applicableCompletedCHU de Quebec-Universite Laval38192013-11-012018-02-22
Multiple Gestation Study
Trisomy 13, Trisomy 18
CompletedNatera, Inc.3542013-03-012019-08-26
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
Trisomy 21, Trisomy 18
CompletedNatera, Inc.10592012-11-012020-12-30
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
Microdeletion Syndromes, Trisomy 21
CompletedNatera, Inc.2162012-10-012019-08-26

Showing 20 of 27. Sign in to see all of them.

Narrower conditions

Down Syndrome (27)  ·  Trisomy 13 Syndrome (23)  ·  Turner Syndrome (13)  ·  Aneuploidy (8)  ·  Sex Chromosome Aberrations (7)  ·  Klinefelter Syndrome (5)  ·  DiGeorge Syndrome (4)  ·  Chromosome Disorders (2)  ·  Trisomy (2)  ·  22q11 Deletion Syndrome (1)  ·  Angelman Syndrome (1)  ·  Chromosome 1p36 Deletion Syndrome (1)  ·  Chromosome Aberrations (1)  ·  Chromosome Deletion (1)

Broader conditions

Abnormalities, Multiple (27)  ·  Cardiovascular Abnormalities (27)  ·  Cardiovascular Diseases (27)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (27)  ·  Genetic Diseases, Inborn (27)  ·  Heart Defects, Congenital (27)  ·  Heart Diseases (27)  ·  Intellectual Disability (27)  ·  Nervous System Diseases (27)  ·  Neurobehavioral Manifestations (27)  ·  Neurologic Manifestations (27)  ·  Congenital Abnormalities (26)  ·  Chromosome Disorders (25)  ·  Endocrine System Diseases (15)  ·  Disorders of Sex Development (14)

Interventions

Blood Specimen Collection (4)  ·  Telbivudine (1)  ·  dichlorobis(azomycin)platinum II (1)

Sponsors

Natera, Inc. (8)  ·  Sequenom, Inc. (4)  ·  Progenity, Inc. (3)  ·  Women and Infants Hospital of Rhode Island (2)  ·  Assiut University (1)  ·  Azienda Usl di Bologna (1)  ·  BillionToOne Inc. (1)  ·  CHU de Quebec-Universite Laval (1)  ·  Cindy Cisneros (1)  ·  Haseki Training and Research Hospital (1)  ·  Lenetix Medical Screening Laboratory (1)  ·  PerkinElmer, Wallac Oy (1)  ·  Premaitha Health (1)  ·  Verinata Health, Inc. (1)

Countries

United States (21)  ·  Italy (4)  ·  Canada (3)  ·  Spain (3)  ·  Ireland (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  France (1)  ·  India (1)  ·  Malaysia (1)  ·  South Korea (1)  ·  Sweden (1)  ·  Taiwan (1)  ·  Turkey (Türkiye) (1)

Top investigators

Richard Porreco, MD (3)  ·  Glenn E Palomaki, PhD (2)  ·  Peer Dar, MD (2)  ·  Allan Bombard, MD (1)  ·  Allan T Bombard, MD (1)  ·  Amy J Sehnert, MD (1)  ·  Asma Khalil, MBBS (1)  ·  Brian Kirshon, MD (1)  ·  Enza Pavanello (1)  ·  Errol Norwitz, MD, PhD (1)  ·  Francois Rousseau, MD MSc FRCPC (1)  ·  Joanne Stone, MD (1)  ·  Julia Wynn, MS, MS, CGC (1)  ·  Kim Martin, MD (1)  ·  Lorraine Dugoff, MD (1)

Results publications

PMID 10417280, PMID 12820840, PMID 16814942, PMID 20375405, PMID 21310373, PMID 21519036, PMID 22005709, PMID 22281937, PMID 22464072, PMID 22617594, PMID 22742782, PMID 23215555, PMID 23613152, PMID 23712453, PMID 24135152, PMID 24388429, PMID 24571752, PMID 24785862, PMID 25004354, PMID 25111587, PMID 25479548, PMID 25834952, PMID 28079901, PMID 31231136, PMID 31510865, PMID 34492029, PMID 34761647, PMID 35033576, PMID 35085538, PMID 35136187, PMID 36103259, PMID 36965866, PMID 41775005, PMID 9647154

NIH funding

R44HD062114 (1)